Cencosud S.A Target Price Update

Similar documents
Parque Arauco. Target Price Update. Investment Thesis. Target price: CLP Recommendation: Sell Risk: Moderate

Initiating Coverage. Investment Thesis and Recommendation. Target Price: CLP 485 Recommendation: Hold Risk: High

Result Estimate for 3Q13

ENERSIS. Initiating Coverage. Investment Thesis and Recommendation. Risks. Target Price: CLP 180 Recommendation: Hold Risk: Medium

Income Report. Our main views regarding the quarterly results reported by the companies under our coverage are voiced in the following comments:

SMSAAM. Initiation of coverage. Associated mid-risk. Recommendation and Investment Thesis. Target price: CLP 67 Recommendation: Hold Risk: Moderate

Pulp Production Installed Capacity 2011-Dec

AES GENER. Initiating Coverage. Investment Thesis and Recommendation. Risks

CMPC. Target Price Update

Back to basics. Recommendation and investment thesis. Strengths and opportunities. Weaknesses and threats

Preparing the soil. Recommendation and investment thesis

Camanchaca. Initial Public Offer

Earnings Presentation. Third. Quarter

SAFARICOM LTD EARNINGS UPDATE MAY 2016

Earnings Presentation FIRST QUARTER 2016

Third Quarter Revenues rose 14% (7% in USD) on the addition of our Colombian supermarket operation and selling space growth of 219,746 m 2

2017-4Q17 E A R N I N G S R E L E A S E

Earnings Presentation Fourth Quarter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 15F. Cencosud S.A. (Exact name of registrant as specified in its charter)

Corporate Presentation Cencosud. Fourth Quarter

2Q16 Highlights: 12M FWD EV/EBITDA 12M PRICE PERFORMANCE VS. IPC P/E

Cencosud S.A. (Translation of registrant s name into English)

Turkcell EARNINGS REVIEW 4Q17. Digital transformation on track BUY

Ripley Corp. November rd Quarter 2016 Results

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90

FLASH NOTE Welspun India 31 Jan 17

Standalone Quarterly results (YE Mar) 1QFY14 1QFY15 % yoy FY13 FY14 % yoy

Q4 EARNINGS REPORT Welspun India 25 Apr 17

September 13 & 14 RESULTS 2 ND QUARTER 2016

Overweight. VIVA Kuwait. Reiterate Overweight raising TP by 25% on lower capex guidance. 26 February 2015 Kuwait Telecoms

Corporate Presentation Cencosud Second Quarter 2011

EARNINGS PRESENTATION Q3 15. November 2015

S.A.C.I. Falabella. EARNINGS REPORT 3 rd Quarter 2017

FINANCIAL REPORT FOURTH QUARTER 2018 MARCH 2019

BUY COCA COLA EMBONOR. Positive 2Q16 Results : Maintaining BUY

O&M in the Last Mile Ezentis manages, maintains and deploys infrastructure for telecommunications and utilities companies.

WALMEX HOLD. Have You Looked at P/BV? (12/14/05) CURRENT PRICE: US$5.81/M$62.35 TARGET PRICE: US$5.70/M$65.00

SACI FALABELLA EARNINGS REPORT 3rd QUARTER 2015

12M11 4Q11. Earnings Release. Sonda S.A. SONDA S.A. 1

Ripley Corp. May st Quarter 2016 Results

CEMEX Cement. Quarterly Report July 27, CX: Proving the success of its Value-before-Volume strategy.

CEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade.

Adjusted EBITDA ,5% ,9% Adjusted EBITDA Margin (%) 7,7% 9,3% -160 bps 7,4% 6,2% 119 bps

RASSINI Automotive Industry

Mahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%)

CIDMEGA Services. Outperformer 2 P$51.0. Quarterly Report October 25, CIDMEGA Market Outperformer 12m FWD Price Target P$51

Quarterly results (YE Mar) 4QFY13 4QFY14 YoY(%) FY13 FY14 YoY(%)

S.A.C.I. Falabella 3rd Quarter 2017 / Earnings Presentation

Quarterly results (YE Mar) 2QFY14 2QFY15 % yoy H1FY14 H1FY15 % yoy

CVC. Equity Research. Another solid sales showing. Latin America Retailing Company Note 07 April 2015

2Q 2017 Earnings Results. September 12, 2017

BIMBO Food. Quarterly Report October 27, BIMBO Market Underperformer 2016 Price Target P$41.9

LARGE CAP & 1,970 BSE

Copel. Equity Research. Big boost from Araucária. Latin America Electric & Other Utilities Company Note 15 May 2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 6 - K

RIPLEY CORP. July 2008

SACI FALABELLA EARNINGS REPORT 2nd QUARTER 2015

Webcast & Teleconference Information: Friday March 2, :00 Chile & 10:00 EST

FINANCIAL REPORT FOURTH QUARTER 2011 FINANCIAL REPORT FIRST QUARTER 2012

InRetail Perú Corp. USD Solid fundamentals, limited upside. EQUITY RESEARCH Update January 6th, What changed in our model?

Repco Home Finance REPCO IN

Ternium Announces Third Quarter and First Nine Months of 2018 Results

S.A.C.I. Falabella 1 st Quarter 2017 / Earnings Presentation

CEMEX (US$24.03) Positive 3Q03 Operating Results and Advances on the Financial Front TARGET PRICE: US$27.00

Earnings Presentation Q2 14

MID TERM FINANCIAL REPORT MARCH 31 ST 2018 MANAGING HIGH VALUE ADDED PROCESSES GLOBALLY 1

Enel Américas Enel Américas 2018 Analyst Update Meeting

SACI FALABELLA EARNINGS REPORT 4th QUARTER 2015

ZAIN KSA. Promising turnaround story OVERWEIGHT UPSIDE +16.3%

3Q13 Conference Call Gerdau S.A. Consolidated IFRS

CENCOSUD S.A. RESULTS 1 ER QUARTER 2016

Multiplan. Equity Research. 4Q13 FFO miss on higher opex. Brazil Real Estate Company Note 24 February 2014

RESULTS Presentation March 8 th, 2018

Ezentis increases its EBITDA by 142,3% in the first nine months of the year up to 16,4 million Euros

Ripley Corp UBS Latam Opportunities

Prosegur FY 2010 Results. Madrid, February 28 th, 2011

Earnings Presentation Q1 2015

GRUPO CONCESIONARIO DEL OESTE S.A. OEST.BA/MERVAL

Balkrishna Industries

CHILEAN EQUITY DASHBOARD

Saudi Arabia BUY. Result Update. Saudi International Petrochemical Company (SIPCHEM) CMP: SR18.2 (as on May 03, 2009) Highlights

KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold

VITRO Conglomerates. Company Note March 1, VITRO completes acquisition of the OEM Business from PGW

Advanced Petrochemicals Co Upgrade to OW. Raise TP to SAR61/share

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

Ripley Corp. One of the biggest holdings of the department store business in Chile and Peru

3Q08 EARNINGS RELEASE

CORPORATE PRESENTATION

Chilean Beverage. Industry prospects and target price update

Multiplan. Equity Research. Buying Barra and Morumbi at very attractive terms

ENERSIS ANNOUNCES CONSOLIDATED RESULTS FOR YEAR ENDED ON DECEMBER 31, Highlights for the Period SUMMARY

BUY (Maintained) Tunas Baru Lampung (TBLA IJ) COMPANY UPDATE. New Raw Sugar Import Quota To Ensure Steady Performance In 2018

CORPBANCA. July 2011

4Q11 Results 4Q11. Executive Summary: Full Year Revenues Increased by 18%, Reaching Ch$ 86,345. million in 2011; 4Q 2011 Revenues up 16.

ENERSIS ANNOUNCES CONSOLIDATED RESULTS FOR THE PERIOD ENDED ON SEPTEMBER 30, Highlights for the Period SUMMARY

DX (Group) plc* Industrial Transportation. Successful HMPO tender improves forecast certainty. Price 17.75p. Price Performance. Financial Forecasts

Market pricing Utilities: Sector outlook

1. Summary of Consolidated Results 4th Quarter Summary of Consolidated Results accumulated as for December

FORM6- K. CencosudS.A.

SACC Stronger growth expected

Transcription:

13-05 -20 13 13-06 -20 13 13-07 -20 13 13-08 -20 13 13-09 -20 13 13-10 -20 13 13-11 -20 13 13-12 -20 13 13-01 -20 14 13-02 -20 14 13-03 -20 14 13-04 -20 14 Cencosud S.A Target Price Update Target Price: CLP 2,400 Recommendation: Buy Risk: High May 13, 2014 Sector: Retail T: +56 2 2660 2187 Company Information Ticker Bloomberg: CENCOSUD CI Equity Closing Price (CLP/share): 1,903.3 12M Price Range: 1,468.5 2,649.2 Daily Volume (millions of CLP): 4,674.8 Shares (millions): 2,828.7 Market Capitalization (thousands of USD): 5,383.9 Shares / ADR: 3 Share Price Investment Thesis We updated our target Price for Cencosud S.A. to CLP 2,400 per share for yearend 2014, with a Buy recommendation and high risk. At the current closing price, our target implies a potential growth of 26.5%. In addition, we expect a dividend yield of 0% for December 2014, totaling a return of 26.5%. Our thesis considers the strong inorganic growth the company has had in recent years and their capacity to successfully consolidate said operations. Successfully consolidate acquired operations in the short-term in Colombia and Brazil increasing operating efficiencies. This has led to a reduction in the margins due to increased expenses associated to the integration of its operations. Nonetheless, we expect an improvement in results of the consolidation of its operations in Colombia and Brazil by the end of 2014, increasing in this way the efficiencies of the company and reducing expenses. 2014 investment plan of USD 425 million, which will increase the sales by 6% YoY. A 30% of the investment will take place in Chile, 20% in Brazil, 18% in Colombia, 20% in Peru and 12% in Argentina. The Capex announced will allow the company to pay debt and take its DFN/EBITDA indebtedness level back to 3.0x thus maintaining its risk classification and complying with covenants established in its bonds. Share Price vs. IPSA Base 100 110 100 90 80 70 60 50 40 High exposure to Argentina, a country experiencing significant political and inflationary problems. We expect a depreciation of the Argentine Peso from ARS 8.01 to ARS 9.72 per dollar in 2014, which could reduce Cencosud s income. If we consider that 28% of the EBITDA comes from that country, the EBITDA of the company would decrease by 5% with the possible depreciation of the Argentine peso. This is partially compensated by the company s strong position in the supermarket segment, which amounts to 74% of its income and 54% of its EBITDA. Risks Consolidation of operations: The execution of the plan could affect the company s value either in a favorable or unfavorable way, inasmuch as that the company exceeds our expectations or not. Country Risk: Political and economic changes that may arise in each country Cencosud operates in. These changes include: changes of the estimated demand, foreign exchange fluctuations, interest rates, taxes, and minimum wages. All these factors could eventually affect the company s value. CENCOSUD Source: Bloomberg, CorpResearch IPSA Cencosud May 16, 2014

Cencosud Target Price (CLP): 2.400 Recomendation: Buy Company Description Cencosud is one of the main conglomerates in Latin-America, present in Chile, Argentina, Brazil, Colombia and Peru. Cencosud has businesses in Supermarkets, Home improvement, department stores, shopping centers and Financial Business. At December, 38% of its income comes from Chile, 25% from Argentina, 20% from Brazil, 8% from Peru and 9% from Colombia. ERR (CLP billions) 2014 2015 2016 Sales 10,341,040 10,531,119 10,978,017 11,470,091 Gross Margin 2,969,491 3,049,723 3,194,811 3,346,491 Gross Margin% 29% 29% 29% 29% Operating Income 624,146 632,119 671,053 720,109 Operating Margin% 6.0% 6.0% 6.1% 6.3% EBITDA 767,790 800,617 846,701 903,630 EBITDA Margin % 7.4% 7.6% 7.7% 7.9% Net Financial Expenses - 252,830-182,944-179,266-176,167 Non-Operating Income - 298,224-255,910-252,672-250,028 Earnings 229,765 229,172 254,486 276,922 EPS (CLP/share) 81 81 90 98 Property Structure Balance (CLP billions) 2014 2015 2016 ADS 1% Cash and cash equivalents 256,131 133,267 309,486 410,596 Non-current assets 7,474,910 7,554,007 7,638,654 7,725,663 Total Assets 10,065,234 9,891,228 10,244,339 10,509,754 Financial Debt 2,957,141 2,732,141 2,822,141 2,822,141 Total Liabilities 5,803,867 5,469,618 5,636,995 5,701,834 Total Equity 4,261,367 4,421,610 4,607,344 4,807,920 Noncontrolling Interest 882 882 882 882 Income Distribution FC (CLP billions) 2014 2015 2016 11% Others 23% Pension Funds 16% 2% 3% 9% Supermarket Departament Store Financial Services Controllin g Group 60% 75% Home Improvement Malls Operating Income 624,146 632,119 671,053 720,109 Adjusted Taxes - 209,218-212,137-227,862-246,934 Depreciation & Amortization 165,457 168,498 175,648 183,521 Capex - - 247,595-260,296-270,530 Δ Working Capital 530,454-12,295 8,708 7,297 Free Cash Flow 1,110,838 328,590 367,252 393,464 Capital Increase - - - - Dividends - 80,901-35,642-68,752-76,346 New Debt - 581,491-225,000 90,000 - Comparables P/E Ratio EV/EBITDA Ratios 2014 2015 2016 Cencosud 23.7 9.96 Share Price (CLP) 1,892 1,897 1,897 1,897 Falabella 26.6 18.5 P / U (x) 23.3 23.4 21.1 19.4 Forus 16.1 11.64 Liabilities/Equity (x) 1.4 1.2 1.2 1.2 Ripley 15.9 13.46 EV / EBITDA (x) 9.4 10.8 9.6 9.1 EBITDA / Financial Expenses (x) 5.6 3.8 4.0 17.4 Net Financial Debt / EBITDA (x) 2.7 3.7 2.9 2.7 ROA (% ) 2.3% 2.3% 2.5% 2.6% β (vs IPSA): 1.29 ROE (% ) 5.4% 5.2% 5.5% 5.8% WACC: 12.0% Dividend Yield (% ) 1.3% 0.7% 1.3% 1.4% Source: CorpResearch, Bloomberg, Company Financial Statements.

Cencosud Income Distribution by Country 10% 8% 19% 25% 38% Chile Argentina Perú Colombia Brasil Source: Company Reports, CorpResearch. Cencosud EBITDA Distribution by Country 6% 8% 6% 28% 52% Investment plan The investment plan published for 2014 decreased when compared to those of due to problems with the sale of the financial retail business, which was finally not completed. The investment should reach USD 425 million this year, where USD 210 million are allocated to the opening of new stores. Additionally, we only consider on time implementation of 95% and delays in 5% of store openings. Based on these assumptions, we estimate a 6% increase in the sales area distributed in this manner: 75% in supermarkets, 21% in Home Improvement and 4% in Department Stores. Therefore, we expect income to increase by 11% within the next 3 years, adding up to CLP 277,214 million by the end of 2016. In any case, we expect the adjustments made to the investment plans to continue until 2016, and then increase gradually. Proyected Store Square Meters Millions M2 4,5 4,0 3,5 3,0 2,5 2,0 1,5 1,0 0,5 2,9 3,5 0,0 2012 Source: Company Reports, CorpResearch 2014E 2015E 2016E Situation in Argentina Argentina is going through a troubled political and economic situation, thus we expect an exchange rate depreciation of 21%. 28% of the Company s EBITDA comes from that country; hence the fall in EBITDA by exchange rate will be 5%. In addition, we expect positive SSS in that country, which are affected by the current high inflationary rates. We do not expect the situation to improve in that country, neither in the short or the medium term.. Exchange Rates ARS/Dólar Consensus Forecast 3,7 3,8 4,0 13,07 9,52 Chile Argentina Perú Colombia Brasil 3,94 4,17 4,64 5,52 7,02 Fuente: Company Reports, CorpResearch. 2010 2011 2012 2014 2015 2016 Source: Concensus Forecast, CorpResearch

Proyected EBITDA & Mg. EBITDA CLP Billions 0,95 0,90 0,85 0,80 0,75 0,70 0,65 7,4% 0,77 7,6% 7,7% 0,81 0,85 7,9% 0,91 2014E 2015E 2016E Source:Company Reports, CorpResearch Price Earnings Ratio 2016 19,34 8,0% 7,9% 7,8% 7,7% 7,6% 7,5% 7,4% 7,3% 7,2% 7,1% Valuation We have valued the company using a discounted cash flow method (DCF) given the economic prospects for the region, its investment plan and its capacity for consolidating its operations. We consider a tax rate of 25% in Chile to calculate the discount rate (WACC). In the case of the adjusted tax, we have increased it gradually from 21% to 24% in 2017. By 2018, we have incorporated the elimination of the FUT, reaching a relevant tax of 35%. Due to lower operating prospects, our target price was reduced compared to our previous report, but we have upgraded our recommendation from Hold to Buy, due to the low price shares have today. Poorer forecasts are mainly due to the tax changes we expect for the next 5 years in Chile. In addition, these estimations are affected by the exchange rate depreciation in the region and the 45% capex reduction aimed at improving the company s leverage level. This new investment plan will make Cencosud exhibit healthy indebtedness ratios again. The income increase of 2.7% in in 2014 is not completely reflected in the EBITDA, since the pressures over costs are going to continue due to the consolidation of the company s acquisitions and new store openings. We estimate that SAGs will show a slight improvement by the end of the year, as a result of the consolidation of the operations in Brazil and Colombia, leading to greater operating efficiencies. This should take the SAGs back to historical levels, which should gradually help take the EBITDA margin back to historical levels of 8.5%, progressively increasing the company s income, which should go up to CLP 232,218 million by the end of 2014. 2015 2014 20,97 23,08 23,30 Cencosud is one of the main Latin American conglomerates, present in Chile, Argentina, Brazil, Colombia and Peru. Cencosud has participation in the Supermarket, Home improvement, Department Store, Shopping Center and Financial Businesses. As of December, 38% of its income comes from Chile, 25% from Argentina, 20% from Brazil, 8% from Peru and 9% from Colombia. 2012 23,54 Proyected Income CLP Billions 2011 2010 Source: Company Reports, CorpResearch 22,55 27,01 12,0 11,5 11,0 10,5 10,0 10,3 10,6 11,0 11,5 9,5 Source: Company Report, CorpResearch 2014E 2015E 2016E

CorpResearch Álvaro Donoso Director CorpResearch adonoso@corpgroup.cl Economic Studies Sebastián Cerda Executive Director CorpResearch and Economic Studies scerda@corpgroup.cl Nicolás Birkner Head of Macroeconomic and Financial Analysis nicolas.birkner@corpgroup.cl Karla Flores Senior Economist karla.flores@corpgroup.cl Variable Income Studies Vicente Meschi Sub-director of Variable Income Studies vicente.meschi@corpgroup.cl Sergio Zapata Senior Analyst. Sectors: Electrical, Utilities. sergio.zapata@corpgroup.cl Cristóbal Casassus Senior Analyst. Sectors: Banking, Transport. cristobal.casassus@corpgroup.cl M Josefina Güell Analyst. josefina.guell@corpgroup.cl Patricio Acuña Analyst. patricio.acuna@corpgroup.cl Martín Antúnez Analyst. Sectors: Construction, Telecommunications. martin.antunez@corpgroup.cl Rosario Norte 660 Piso 17, Las Condes, Santiago. Phone: +562 2660 3600 www.corpbancainversiones.cl IMPORTANT US REGULATORY DISCLOSURES ON SUBJECT COMPANIES

This material was produced by CorpResearch, solely for information purposes and for the use of the recipient. It is not to be reproduced under any circumstances and is not to be copied or made available to any person other than the recipient. It is distributed in the United States of America by Enclave Capital LLC (19 West 44th Street, Suite 1700, New York, NY 10036). Enclave is a broker-dealer registered with the SEC and a member of FINRA and the Securities Investor Protection Corporation, only to major U.S. institutional investors, as defined under Rule 15a-6 (a) (2) promulgated under the US Securities Exchange Act of 1934, as amended, and as interpreted by the staff of the US Securities and Exchange Commission. This document does not constitute an offer of, or an invitation by or on behalf of CorpResearch or its Head Office, Corpbanca or any other company to any person, to buy or sell any security. The information contained herein has been obtained from published information and other sources, which CorpResearch consider to be reliable. None of CorpResearch or its Head Office, Corpbanca, accepts any liability or responsibility whatsoever for the accuracy or completeness of any such information. All estimates, expressions of opinion and other subjective judgments contained herein are made as of the date of this document. Emerging securities markets may be subject to risks significantly higher than more established markets. In particular, the political and economic environment, company practices and market prices and volumes may be subject to significant variations. The ability to assess such risks may also be limited due to significantly lower information quantity and quality. By accepting this document, you agree to be bound by all the foregoing provisions. 1. CorpResearch or its Head Office, Corpbanca, may or may not have been beneficial owners of the securities mentioned in this report. 2. CorpResearch or its Head Office, Corpbanca, may have or not managed or co-managed a public offering of the securities mentioned in the report in the past 12 months. 3. CorpResearch or its Head Office, Corpbanca, may have or not received compensation for investment banking services from the issuer of these securities in the past 12 months and do not expect to receive compensation for investment banking services from the issuer of these securities within the next three months. 4. However, one or more of CorpResearch or its Head Office, Corpbanca may, from time to time, have a long or short position in any of the securities mentioned herein and may buy or sell those securities or options thereon either on their own account or on behalf of their clients. 5. As of the publication of this report CorpResearch does not make a market in the subject securities. 6. CorpResearch or its Head Office, Corpbanca, may or may not, to the extent permitted by law, act upon or use the above material or the conclusions stated above or the research or analysis on which they are based before the material is published to recipients and from time to time provide investment banking, investment management or other services for or solicit to seek to obtain investment banking, or other securities business from, any entity referred to in this report. Enclave Capital LLC is distributing this document in the United States of America. CorpResearch accepts responsibility for its contents. Any US customer wishing to effect transactions in any securities referred to herein or options thereon should do so only by contacting a representative of Enclave Capital LLC. This investment research is not intended for use by any person or entity that is not a major US institutional investor. If you have received a copy of this research and are not a major U.S institutional investor, you are instructed not to read, rely on or reproduce the contents hereof, and to destroy this research or return it to CorpResearch or to Enclave. Analyst(s) preparing this report are employees of CorpResearch who are resident outside the United States and are not associated persons or employees of any US registered broker-dealer. Therefore, the analyst(s) are not be subject to Rule 2711 of the Financial Industry Regulatory Authority (FINRA) or to Regulation AC adopted by the US Securities and Exchange Commission (SEC) which among other things, restrict communications with a subject company, public appearances and personal trading in securities by a research analyst. Any major U.S Institutional investor wishing to effect transactions in any securities referred to herein or options thereon should do so by contacting a representative of Enclave Capital LLC.